| Female Reproductive System Carcinosarcoma studied in …STUDIED_INderived59 of 59show fewer |
|---|
| → studied in | NCT05256225Phase 3 · recruiting Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma · condition mapped ONTOLOGY_EXACT · 59 trials mapped (19 active) | — | — | Uterine Corpus Malignant Mixed Mesodermal (Mullerian) Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05920798Phase 1/Phase 2 · active not recruiting Vaccine Therapy Plus Pembrolizumab in Treating Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer · condition mapped ALIAS · 59 trials mapped (19 active) | — | — | Fallopian Tube Malignant Mixed Mesodermal (Mullerian) Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02101775Phase 2 · active not recruiting Gemcitabine Hydrochloride With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer · condition mapped ONTOLOGY_EXACT · 59 trials mapped (19 active) | — | — | Ovarian Malignant Mixed Mesodermal (Mullerian) Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03651206Phase 2/Phase 3 · recruiting Recurrent Ovarian CarcinoSarcoma Anti-pd-1 Niraparib · condition mapped ONTOLOGY_EXACT · 59 trials mapped (19 active) | — | — | Ovarian Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07741968NA · recruiting A Blended e-Health Intervention to Improve Fear of Progression in Women With Gynecologic or Breast Cancer · condition mapped ONTOLOGY_EXACT · 59 trials mapped (19 active) | — | — | Ovarian Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06580314Phase 3 · recruiting Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer · condition mapped ONTOLOGY_EXACT · 59 trials mapped (19 active) | — | — | Fallopian Tube Malignant Mixed Mesodermal (Mullerian) Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03120624Phase 1 · active not recruiting VSV-hIFNbeta-NIS With or Without Ruxolitinib Phosphate in Treating Stage IV or Recurrent Endometrial Cancer · condition mapped CURATED_BROADER · 59 trials mapped (19 active) | — | — | Uterine Corpus Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04092270Phase 1 · active not recruiting A Study Combining the Peposertib (M3814) Pill With Standard Chemotherapy in Patients With Ovarian Cancer With an Expansion in High Grade Serous Ovarian Cancer and Low Grade Serous Ovarian Cancer · condition mapped ONTOLOGY_EXACT · 59 trials mapped (19 active) | — | — | Fallopian Tube Malignant Mixed Mesodermal (Mullerian) Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03449108Phase 2 · active not recruiting LN-145 or LN-145-S1 in Treating Patients With Relapsed or Refractory Ovarian Cancer, Triple Negative Breast Cancer (TNBC), Anaplastic Thyroid Cancer, Osteosarcoma, or Other Bone and Soft Tissue Sarcomas · condition mapped ONTOLOGY_EXACT · 59 trials mapped (19 active) | — | — | Ovarian Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05049538recruiting Determine the Utility of Liquid Biopsies and Tumor Molecular Profiling in Predicting Recurrence in Endometrial Cancers · condition mapped ONTOLOGY_EXACT · 59 trials mapped (19 active) | — | — | Uterine Corpus Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01737619NA · active not recruiting PET/CT and Lymph Node Mapping in Finding Lymph Node Metastasis in Patients With High-Risk Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 59 trials mapped (19 active) | — | — | Malignant Mixed Mesodermal (Mullerian) Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05156268Phase 2 · completed A Study of Pembrolizumab and Olaparib in People With Endometrial Cancer or Endometrial Carcinosarcoma · condition mapped ALIAS · 59 trials mapped (19 active) | — | — | Uterine Corpus Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02874430Phase 2 · terminated Metformin Hydrochloride and Doxycycline in Treating Patients With Localized Breast or Uterine Cancer · condition mapped ONTOLOGY_EXACT · 59 trials mapped (19 active) | — | — | Uterine Corpus Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03694262Phase 2 · completed The EndoBARR Trial (Endometrial Bevacizumab, Atezolizumab, Rucaparib) · condition mapped ONTOLOGY_EXACT · 59 trials mapped (19 active) | — | — | Uterine Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04919629Phase 2 · recruiting APL-2 and Pembrolizumab Versus APL-2, Pembrolizumab and Bevacizumab Versus Bevacizumab Alone for the Treatment of Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer and Malignant Effusion · condition mapped ALIAS · 59 trials mapped (19 active) | — | — | Fallopian Tube Malignant Mixed Mesodermal (Mullerian) Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05500391Phase 2 · recruiting Assessment of Compliance With Monitoring Conducted by a Physician in Person or by a Nurse in Remote Monitoring · condition mapped ONTOLOGY_EXACT · 59 trials mapped (19 active) | — | — | Ovarian Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06483048Phase 1 · recruiting MUC1-Activated T Cells for the Treatment of Relapsed and Resistant Ovarian Cancer · condition mapped CURATED_BROADER · 59 trials mapped (19 active) | — | — | Fallopian Tube Malignant Mixed Mesodermal (Mullerian) Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05494580Phase 1/Phase 2 · completed Pamiparib Plus Surufatinib in Patients With Platinum-resistant Ovarian Cancer · condition mapped ALIAS · 59 trials mapped (19 active) | — | — | Fallopian Tube Malignant Mixed Mesodermal (Mullerian) Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03422198Phase 3 · recruiting Short Course Vaginal Cuff Brachytherapy in Treating Participants With Stage I-II Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 59 trials mapped (19 active) | — | — | Uterine Corpus Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02364713Phase 2 · terminated MV-NIS or Investigator's Choice Chemotherapy in Treating Patients With Ovarian, Fallopian, or Peritoneal Cancer · condition mapped ALIAS · 59 trials mapped (19 active) | — | — | Fallopian Tube Malignant Mixed Mesodermal (Mullerian) Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05902988Phase 1/Phase 2 · recruiting A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer · condition mapped ONTOLOGY_EXACT · 59 trials mapped (19 active) | — | — | Ovarian Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05229601Phase 1 · terminated A Study of HFB301001 in Adult Patients With Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 59 trials mapped (19 active) | — | — | Uterine Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04106414Phase 2 · active not recruiting Study of BMS-986205 and Nivolumab in Endometrial Cancer or Endometrial Carcinosarcoma That Has Not Responded to Treatment · condition mapped ALIAS · 59 trials mapped (19 active) | — | — | Uterine Corpus Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06639074Phase 2 · recruiting Folate Receptor Alpha Dendritic Cells (FRαDCs) or Placebo for the Treatment of Patients With Stage III or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer, FAROUT Trial · condition mapped CURATED_BROADER · 59 trials mapped (19 active) | — | — | Ovarian Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01935934Phase 2 · completed Cabozantinib S-Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 59 trials mapped (19 active) | — | — | Uterine Corpus Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06393751Phase 1/Phase 2 · withdrawn Testing the Addition of ASTX660 (Tolinapant) to the Usual Chemotherapy Treatment (Paclitaxel With or Without Bevacizumab) in Patients With Recurrent Ovarian Cancer · condition mapped CURATED_BROADER · 59 trials mapped (19 active) | — | — | Fallopian Tube Malignant Mixed Mesodermal (Mullerian) Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03610490Phase 2 · terminated Autologous Tumor Infiltrating Lymphocytes MDA-TIL in Treating Patients With Recurrent or Refractory Ovarian Cancer, Colorectal Cancer, or Pancreatic Ductal Adenocarcinoma · condition mapped CURATED_BROADER · 59 trials mapped (19 active) | — | — | Ovarian Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04802876Phase 2 · active not recruiting Efficacy of Tislelizumab and Spartalizumab Across Multiple Cancer-types in Patients with PD1-high MRNA Expressing Tumors · condition mapped ONTOLOGY_EXACT · 59 trials mapped (19 active) | — | — | Uterine Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03552471Phase 1 · completed Mirvetuximab Soravtansine and Rucaparib Camsylate in Treating Participants With Recurrent Endometrial, Ovarian, Fallopian Tube or Primary Peritoneal Cancer · condition mapped CURATED_BROADER · 59 trials mapped (19 active) | — | — | Uterine Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04906382early Phase 1 · terminated Tislelizumab for the Treatment of Recurrent Mismatch Repair Deficient Endometrial Cancer · condition mapped CURATED_BROADER · 59 trials mapped (19 active) | — | — | Uterine Corpus Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03648489Phase 2 · completed Dual mTorc Inhibition in advanCed/Recurrent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer (of Clear Cell, Endometrioid and High Grade Serous Type, and Carcinosarcoma) · condition mapped ONTOLOGY_EXACT · 59 trials mapped (19 active) | — | — | Ovarian Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03206177Phase 1 · completed Paclitaxel/Carboplatin + Galunisertib for Patients With Carcinosarcoma of the Uterus or Ovary · condition mapped ONTOLOGY_EXACT · 59 trials mapped (19 active) | — | — | Ovarian Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05001282Phase 1/Phase 2 · terminated A Study to Evaluate ELU001 in Patients With Solid Tumors That Overexpress Folate Receptor Alpha (FRα) · condition mapped ALIAS · 59 trials mapped (19 active) | — | — | Uterine Corpus Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02020707Phase 1 · completed Nab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological Cancers · condition mapped ONTOLOGY_EXACT · 59 trials mapped (19 active) | — | — | Cervical Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03015129Phase 2 · completed A Study of Durvalumab With or Without Tremelimumab in Endometrial Cancer · condition mapped ALIAS · 59 trials mapped (19 active) | — | — | Uterine Corpus Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03641287NA · terminated The Effects of Exercise on Distress, Quality of Life, and Biomarkers in Ovarian Cancer Survivors · condition mapped ALIAS · 59 trials mapped (19 active) | — | — | Fallopian Tube Malignant Mixed Mesodermal (Mullerian) Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01367301NA · terminated Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With Uterine Cancer · condition mapped ONTOLOGY_EXACT · 59 trials mapped (19 active) | — | — | Uterine Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05537844unknown Longitudinal Sample Collection to Investigate Adaptation and Evolution of Ovarian High-grade Serous Carcinoma · condition mapped ONTOLOGY_EXACT · 59 trials mapped (19 active) | — | — | Ovarian Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03924245Phase 1 · terminated Olaparib and Entinostat in Patients With Recurrent, Platinum-Refractory, Resistant Ovarian, Primary Peritoneal, Fallopian Tube Cancers · condition mapped ALIAS · 59 trials mapped (19 active) | — | — | Fallopian Tube Malignant Mixed Mesodermal (Mullerian) Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00989651Phase 1 · completed Carboplatin, Paclitaxel, Bevacizumab, and Veliparib in Treating Patients With Newly Diagnosed Stage II-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer · condition mapped ALIAS · 59 trials mapped (19 active) | — | — | Fallopian Tube Malignant Mixed Mesodermal (Mullerian) Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00954174Phase 3 · unknown Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed, Persistent or Recurrent Uterine, Ovarian, Fallopian Tube, or Peritoneal Cavity Cancer · condition mapped ONTOLOGY_EXACT · 59 trials mapped (19 active) | — | — | Ovarian Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02993705Phase 2 · completed Trial On Trabectedin In The Treatment Of Advanced Uterine And Ovarian Carcinosarcoma (CS) · condition mapped ONTOLOGY_EXACT · 59 trials mapped (19 active) | — | — | Ovarian Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03902379NA · withdrawn Web-Based Coping and Communication Skills Intervention in Improving Psychological Adaptation in Patients With Gynecological Cancer · condition mapped ONTOLOGY_EXACT · 59 trials mapped (19 active) | — | — | Uterine Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00478426Phase 2 · completed Sunitinib Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 59 trials mapped (19 active) | — | — | Uterine Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01168232Phase 2 · completed Ixabepilone in Treating Patients With Recurrent or Persistent Uterine Cancer · condition mapped ONTOLOGY_EXACT · 59 trials mapped (19 active) | — | — | Uterine Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01247571Phase 2 · completed Pazopanib Hydrochloride in Treating Patients With Recurrent or Persistent Uterine Cancer · condition mapped ONTOLOGY_EXACT · 59 trials mapped (19 active) | — | — | Uterine Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00025506Phase 2 · completed Thalidomide in Treating Patients With Recurrent or Persistent Carcinosarcoma of the Uterus · condition mapped ONTOLOGY_EXACT · 59 trials mapped (19 active) | — | — | Uterine Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00075400Phase 2 · completed Imatinib Mesylate in Treating Patients With Recurrent or Persistent Uterine Cancer · condition mapped ONTOLOGY_EXACT · 59 trials mapped (19 active) | — | — | Uterine Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00085358Phase 1 · completed Carboplatin and Paclitaxel With or Without Bevacizumab Compared to Docetaxel, Carboplatin, and Paclitaxel in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Carcinoma (Cancer) · condition mapped ONTOLOGY_EXACT · 59 trials mapped (19 active) | — | — | Ovarian Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01010126Phase 2 · completed Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer · condition mapped ONTOLOGY_EXACT · 59 trials mapped (19 active) | — | — | Ovarian Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00114218Phase 2 · completed Gemcitabine and Docetaxel in Treating Patients With Recurrent or Persistent Uterine Cancer · condition mapped ONTOLOGY_EXACT · 59 trials mapped (19 active) | — | — | Uterine Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00659360Phase 2 · completed AZD0530 in Treating Patients With Recurrent Locally Advanced or Metastatic Soft Tissue Sarcoma · condition mapped ONTOLOGY_EXACT · 59 trials mapped (19 active) | — | — | Uterine Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01080521completed Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy · condition mapped ONTOLOGY_EXACT · 59 trials mapped (19 active) | — | — | Ovarian Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00511992Phase 2 · completed Study of Bevacizumab Followed by Bevacizumab Consolidation for Ovarian Cancer · condition mapped ONTOLOGY_EXACT · 59 trials mapped (19 active) | — | — | Ovarian Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01061606Phase 2 · terminated Temsirolimus in Treating Patients With Recurrent or Persistent Cancer of the Uterus · condition mapped ONTOLOGY_EXACT · 59 trials mapped (19 active) | — | — | Uterine Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00390234Phase 2 · completed Ziv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue Sarcoma · condition mapped ONTOLOGY_EXACT · 59 trials mapped (19 active) | — | — | Ovarian Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00238121Phase 2 · completed Sorafenib in Treating Patients With Advanced or Recurrent Uterine Cancer · condition mapped ONTOLOGY_EXACT · 59 trials mapped (19 active) | — | — | Uterine Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00352300Phase 1 · completed Carboplatin, Paclitaxel, and Pegfilgrastim in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, Primary Peritoneal, or Carcinosarcoma Cancer · condition mapped ONTOLOGY_EXACT · 59 trials mapped (19 active) | — | — | Ovarian Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00245102Phase 2 · completed Sorafenib in Treating Patients With Metastatic, Locally Advanced, or Recurrent Sarcoma · condition mapped ONTOLOGY_EXACT · 59 trials mapped (19 active) | — | — | Uterine Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |